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Abstract
The mechanisms of hypoxic injury to the developing human brain are poorly understood, despite being a major cause of
chronic neurodevelopmental impairments. Recent work in the invertebrate Caenorhabditis elegans has shown that hypoxia
causes discrete axon pathfinding errors in certain interneurons and motorneurons. However, it is unknown whether
developmental hypoxia would have similar effects in a vertebrate nervous system. We have found that developmental
hypoxic injury disrupts pathfinding of forebrain neurons in zebrafish (Danio rerio), leading to errors in which commissural
axons fail to cross the midline. The pathfinding defects result from activation of the hypoxia-inducible transcription factor
(hif1) pathway and are mimicked by chemical inducers of the hif1 pathway or by expression of constitutively active hif1a.
Further, we found that blocking transcriptional activation by hif1a helped prevent the guidance defects. We identified
ephrinB2a as a target of hif1 pathway activation, showed that knock-down of ephrinB2a rescued the guidance errors, and
showed that the receptor ephA4a is expressed in a pattern complementary to the misrouting axons. By targeting a
constitutively active form of ephrinB2a to specific neurons, we found that ephrinB2a mediates the pathfinding errors via a
reverse-signaling mechanism. Finally, magnesium sulfate, used to improve neurodevelopmental outcomes in preterm
births, protects against pathfinding errors by preventing upregulation of ephrinB2a. These results demonstrate that
evolutionarily conserved genetic pathways regulate connectivity changes in the CNS in response to hypoxia, and they
support a potential neuroprotective role for magnesium.
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Introduction
Hypoxic injury to the developing human brain is a major cause
of both acute and chronic neurodevelopmental impairments.
Premature infants, particularly those characterized by very-low
birth weights (VLBW; less than 1,500 g) are the population at
greatest risk for chronic hypoxic injury and for adverse
neurocognitive outcomes [1]. Causes of hypoxia in these infants
include chronic lung disease, pulmonary hypertension, congenital
heart disease, and placental insufficiency. Up to 35% of VLBW
infants experience neurodevelopmental impairments including
attention-deficit disorder, autism, cerebral palsy, epilepsy, psychi-
atric disorders, and mental retardation/cognitive impairment [2–
5]. While survival rates have improved dramatically for premature
infants, neurodevelopmental outcomes have not [6,7]; in fact, the
total number of VLBW infants has increased over the past decade
[8].
Strategies to protect against the effects of prematurity and
chronic hypoxic injury to the central nervous system (CNS) have
been limited since the pathophysiology that leads to the adverse
neurodevelopmental outcomes is uncertain. Indirect measures in
humans have shown altered connectivity in the brains of children
born prematurely [9,10], and the period between 20 weeks
gestation and term birth (40 weeks gestation) is a period of
extensive commissural and projection axon extension [11]. Most
VLBW infants are born between 23 and 28 weeks gestation, and
both pre-term and term infants experience episodic, often
unrecognized, hypoxemia [12].
The mechanisms by which hypoxia disrupts connectivity in
vertebrates are not known. Recent work in the invertebrate C.
elegans has shown that hypoxia causes discrete axon pathfinding
errors in certain interneurons and motorneurons by increased
expression of the Eph receptor vab-1 [13]. However, it is unknown
whether similar pathfinding errors, and similar genetic pathways
and molecular mechanism, also occur in the more complex
vertebrate CNS.
We hypothesized that hypoxia might specifically affect axon
pathfinding and the development of CNS connectivity in
vertebrates. To test this we developed a zebrafish (Danio rerio)
model for investigating hypoxia at different stages of CNS
development, and generated transgenic lines to test the genetic
pathways involved. We analyzed both genetic and chemical
modifiers of the molecular response of hypoxia on pathfinding,
including cloning zebrafish hif1a and generating a constitutively
active form of it. We found that hypoxia disrupts axon pathfinding
in vertebrates through an evolutionarily conserved mechanism, by
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ephrinB2. Further, we tested the role of magnesium sulfate, which is
known to improve neurodevelopmental outcomes when given to
mothers of infants at risk for premature delivery [14]. We found
that magnesium sulfate helps reduce hypoxia-induced upregula-
tion of ephrinB2, and decreases the frequency of pathfinding errors.
Results
We developed a system in zebrafish to examine the effects of
hypoxia on the development of CNS connectivity. We used a
small, airtight plexiglass chamber in which zebrafish embryos were
placed at different developmental stages. Hypoxia was induced by
use of a digital controller that regulated nitrogen gas flow, and we
pre-equilibrated solutions to either normoxia or hypoxia for at
least 4 hours before use. Previous reports have shown that early
zebrafish embryos tolerate anoxia, especially before 24 hours post-
fertilization (hpf), but the anoxia can slow development [15,16].
Because we wanted to model hypoxic insults to CNS development,
we tested a wide range of hypoxic conditions at different times to
determine the degree of hypoxia that embryos could tolerate with
minimal mortality (Table 1). We assessed mortality at 72 hpf, at
which point major stages of CNS development have occurred,
including neurogenesis, cell-type specification, axon pathfinding,
and synaptogenesis, following either 12 or 24 hour periods of
hypoxia, using at least 30 embryos per condition. We found that
zebrafish embryos can tolerate long periods of stringent hypoxia,
especially at earlier developmental stages. Because we noted
dysmorphic development in embryos exposed to 0.5% hypoxia
(0.5% pO2) or lower, we used 1% hypoxia (1% pO2; normoxia is
21% pO2) for experiments.
Developmental hypoxia causes axon pathfinding errors
To visualize effects of hypoxia on pathfinding, we evaluated
several different transgenic lines as well as a pan-axonal antibody
against acetylated tubulin. Using anti-acetylated tubulin, we found
at low frequency subtle pathfinding errors. Further, in less than
5% of embryos we found severe axon pathfinding errors, most
often of commissural axon tracts (Figure 1A, 1B). However,
because of the low frequency of severe errors and difficulty
visualizing and quantifying the subtle errors using anti-acetylated
tubulin, we generated a transgenic line in which a small subset of
axons expressed membrane-targeted GFP: Tg(foxP2-enhancer-
A.2:egfp-caax). This line precisely labeled a few distinct neuron
types, with retinal, commissural, and longitudinal axons [17]
(Figure 1C).
We examined axon tracts in Tg(foxP2-enhancerA.2:egfp-caax)
embryos following 12-hour periods of hypoxia, and found a
reproducible defect in formation of the tract of the commissure of
the posterior tuberculum (TCPT) [18]. This defect was never seen
in wild-type embryos (Figure 1D), and there was no overall
difference in fluorescence intensities of normoxic compared to
hypoxic transgenic embryos. Following hypoxia, the TCPT
commissure (TCPTc) either did not form, or had fewer axons
crossing.
We noted significant variability in the severity of the phenotype,
with some embryos lacking the TCPTc, some with a normal
appearance to the TCPTc, and some embryos with intermediate
phenotypes. The intermediate phenotypes were embryos in which
the number of TCPTc axons was reduced. The percentage of
embryos with loss or near-complete absence of the TCPTc
following 1% pO2 from 24–36 hpf was 60% (Figure 1E), with no
significant effects of hypoxia when examined at other time-points.
Because of the potential for subjectivity in scoring intermediate
phenotypes of disrupted TCPTc, and in order to increase our
ability to detect more subtle changes in the number of TCPTc
axons crossing, we developed a quantitative measure of TCPTc
axon crossing. We compared fluorescence intensity ratios of
commissural to longitudinal axons of the TCPT axons, in
normoxic versus hypoxic embryos (C/L ratio; Figure 1F; Meth-
ods). The average ratio for normoxic embryos was 0.639, whereas
for hypoxic embryos (1% pO2 from 24–36 hpf) the average was
statistically different at 0.225 (p,0.0001 for two-tailed t test)
(Table 2). Thus, a decrease in the C/L ratio represents a decrease
in the number of axons crossing in the TCPTc.
We examined the effects of hypoxia exposure at different
developmental stages (Figure 1G), with at least 24 embryos for
each period, and analysis at 72 hpf. We found that hypoxia during
24 36 hpf disrupted TCPTc formation, as shown by the
statistically significant decrease in the C/L ratio. Increased
duration of hypoxia up to 36 hours did not worsen the C/L
ratio. Further, when we analyzed the TCPTc at 96 hpf, following
hypoxia from 24–36 hpf, there was persistent failure of TCPTc
crossing (Figure 1H, 1I). Our hypoxia conditions for 12 hours
were therefore followed by either 36 or 60 hours of recovery in
Author Summary
How hypoxia damages the developing human brain is
poorly understood, despite being a major cause of life-
long neurologic and psychiatric problems. Premature
infants are especially at risk for these problems, with
increased rates of attention-deficit disorder, autism,
cerebral palsy, epilepsy, psychiatric disorders, and cogni-
tive impairment. It is unknown whether hypoxia can cause
errors in the connections of neurons in the vertebrate
nervous system. We used zebrafish, a vertebrate model
animal, to answer this question. We found that hypoxic
injury causes errors in how neurons connect. We went on
to determine that a specific genetic pathway, the hif1
pathway, is activated by hypoxia and turns on downstream
genes, which cause the connection problems. One of the
genes activated by hif1, ephrinB2a, is responsible for many
of the connection problems. Importantly, magnesium,
used as a treatment for some preterm births, is able to
help protect against the neuron connection errors. Our
results show that hypoxia in vertebrates does cause errors
in neuron connections and that magnesium can help
prevent this.
Table 1. Hypoxia and survival.
Hypoxia
conditions (% pO2)
Timing of
hypoxia (hpf)
Survival (%
alive at 72 hpf)
normoxia (21%) n/a 100%
8% 24–48 hpf 100%
8% 48–72 100%
2% 24–48 100%
2% 48–72 100%
1% 24–48 100%
1% 48–72 0%
Table of survival percentages following hypoxia exposure in embryonic
zebrafish at different ages. 30 or more embryos were examined for each time-
point.
doi:10.1371/journal.pgen.1002638.t001
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due to a simple maturational delay in axon extension, and that the
TCPT axons do not then re-cross the midline.
To determine whether the observed pathfinding phenotype
following hypoxia correlates with the timing of TCPTc formation,
we examined normal development of TCPT axons. The first
axons project by 24 hpf (Figure 2A), and by 36 hpf axons are
crossing the midline and forming the TCPTc (Figure 2B).
Therefore, our observation that maximal effects of hypoxia occur
when embryos are exposed from 24 to 36 hpf is consistent with the
timing of axon pathfinding.
We then examined the fate of the aberrant axons following
hypoxia. Normally, the TCPT axons in Tg(foxP2-enhancerA.2:egfp-
caax) embryos split (Figure 2C) into commissural and longitudinal
portions, with the majority of axons crossing. In contrast, following
hypoxia, most axons fail to cross the midline and turn to
aberrantly follow a longitudinal pathway (Figure 2D). High-
resolution pictures of the TCPTc following hypoxia (Figure 2E–
2G90) show that the TCPTc axons destined to cross the midline
arise dorsally and remain tightly bundled as they cross the midline
(Figure 2E–2E0). In contrast, following hypoxia, the TCPT axons
split, with some crossing the TCPTc, whereas others turn caudally
and join the longitudinal, more ventral tracts (Figure 2F–2G90).
Thus, the TCPTc hypoxia phenotype is characterized by axons
specifically turning to follow an erroneous pathway.
Possible explanations for the observed disruption in axon
pathfinding could be a general effect on CNS patterning; on
neuron specification; or on apoptosis or cellular proliferation. To
address these possibilities, we compared hypoxic embryos to
normoxic embryos using a variety of cellular markers (Figure 3).
We did not find any significant changes in a variety of markers,
including dlx2 for CNS forebrain and diencephalon patterning,
TH antibody staining for cell-type specification of tyrosine
hydroxylase-expressing neurons, acridine orange for apoptosis, and
anti-phosphohistone H3 antibody for proliferation. We quantified
apoptosis at 72 hpf in a region of the telencephalon that includes
TCPT neuron cell bodies, and found no significant difference
between normoxic and hypoxic embryos (cell counts 6.5 in
normoxia, 7.1 in hypoxia, standard deviation 4.6, n=30 embryos,
p=0.6; Figure 3; Methods).
Hif1a mediates hypoxia’s effects on pathfinding
Cellular responses to hypoxia are coordinated by activation of
the hif1 pathway [19]. hif1a is a basic helix-loop-helix transcription
factor ubiquitously expressed, but which is normally hydroxylated
and degraded under normoxic conditions. In hypoxia hif1a
hydroxylation is inhibited, and hif1a is able to activate a
Figure 1. Hypoxia disrupts axon pathfinding in the developing
CNS. Confocal images are maximum intensity projections of whole-
mount embryos, ventral views, rostral top, scale bars 50 mm. (A, B)
48 hpf embryos, acetylated tubulin immunohistochemistry. (B) Follow-
ing 1% hypoxia (1% pO2) from 24–36 hpf, anterior commissure and
post-optic commissural tracts are disrupted (arrows). (C–I) Tg(foxP2-
enhancerA.2:egfp-caax) embryos (abbreviated foxP2-A.2:caax), GFP
immunohistochemistry. (C) Normoxic embryo at 72 hpf; TCPT commis-
sure (TCPTc) (arrow). (D) Embryo following hypoxia from 24–36 hpf;
TCPTc is absent (arrow). (E) Graph showing percent Tg(foxP2-A.2:caax)
embryos with wild-type TCPTc following hypoxia exposure at different
ages. Error bars standard error of the proportion; ** p,0.0001. (F) C/L
ratio determination. Confocal image of 72 hpf embryos illustrating
determination of ratio of commissure intensity to intensity of
longitudinal axons. (G) Quantification of TCPTc errors in Tg(foxP2-
A.2:caax) embryos following hypoxia exposure at different ages. C/L
(commissure:longitudinal) intensity ratio quantification along y-axis.
*p,0.05; ** p,0.0001. ‘mark indicates significant mortality at this
stage. Errors bars standard error of the mean. (H) Normoxic embryo at
96 hpf; TCPT is intact (arrow). (I) Embryo at 96 hpf following 1% hypoxia
from 24–36 hpf; TCPTc is absent (arrow).
doi:10.1371/journal.pgen.1002638.g001
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organism’s response to hypoxia, for example, by increased
angiogenesis, [20]. We wished to determine whether hif1 pathway
activation was mediating the TCPTc pathfinding errors. First, we
wanted to establish whether hif1 pathway activation was occurring
from our hypoxia model. We decided to examine expression of
igfbp-1, a known downstream transcriptional target of hif1 pathway
activation from hypoxia in vertebrates, including zebrafish and
humans [21–24]. Following hypoxia from 24–36 hpf, igfbp-1
expression was increased (Figure 4A, 4B). To demonstrate a role
for hif1a, we used dimethyloxaloglycine (DMOG) to activate hif1a
by inhibition of prolyl hydroxylase or factor inhibiting hypoxia-
inducible factor [25], in the absence of hypoxia. Normoxic
embryos were exposed to varying DMOG amounts from 24–
36 hpf. Increasing amounts of DMOG led to increasing
expression of igfbp-1 (Figure 4C); and increased pathfinding errors
of the TCPTc (n.26 embryos for all conditions) (Figure 4D;
Table 2). Further, an inhibitor of hif1a transcription CAY10585
[26] was able to reduce the C/L ratio in hypoxia (Figure 4K).
These results suggest that the TCPT commissure errors due to
hypoxia are caused by activation of the hif1 pathway.
Pathfinding errors are cell-intrinsic to the effects of
hypoxia
To determine whether hif1a’s role on the TCPT commissure is
cell-autonomous, we decided to misexpress hif1a or hif1a
mut,a
constitutively active form of hif1a, using the UAS/GAL4 system
[27]. We cloned the zebrafish hif1a cDNA, and then made hif1a
mut
bychanging proline621toalanine inthe conserved LXXLAPmotif
of HIF-1a [28]. We generated stable transgenic lines expressing
hif1a or hif1a
mut downstream of UAS, with a viral 2A peptide fused
to GFP-caax or RFP-caax to generate a bicistronic message [29].
The use of the bicistronic message allowed us to monitor whether
expression of hif1a or hif1a
mut was occurring from the UAS, by the
presence of fluorophore expression. We drove expression either in
the TCPT neurons using Tg(foxP2-enhancerA.2:Gal4-VP16), or pan-
neuronally using Tg(elavl3:Gal4-VP16) (Figure 4E–4K). We did not
observe any TCPTc pathfinding errors when we expressed either
Figure 2. Hypoxia acts during development of the TCPTc by
disrupting axon pathfinding. Confocal whole-mount images, anti-
GFP immunohistochemistry, of Tg(foxP2-A.2:caax) embryos, ventral
views, rostral top, except as noted images are maximum intensity
projections, scale bars 50 mm except E–E9 and H9 25 mm; H0 12.5 mm. (A)
Embryo at 24 hpf, cell bodies and initial axon processes are visible. (B)
Embryo at 36 hpf; TCPTc has formed (arrowhead, magnified in inset).
(C) TCPTc has formed completely by 72 hpf in normoxia. (D) Disruption
of TCPTc in hypoxia. Dotted line shows the subsequent high-resolution
pictures from the inset boxes: E–E0 from the left hand TCPTc with
normal pathfinding; F–F0 with the disrupted TCPTc. (E) Higher
magnification views of embryo at 72 hpf, single confocal slices,
showing decussation of TCPT commissural and longitudinal axon tracts
at different dorsal-ventral levels. (E9) Inset from dorsal-most level, single
confocal slice, shows TCPTc arises as a single axon tract. (E0) Schematic
of (E9) showing the single tract that will give rise to the TCPTc. (F)
Mirror-images of the disrupted TCPTc from the right-hand of image (D),
single confocal slices. The dorsal-most image shows the disrupted axon
pathfinding. (F9) High-resolution single confocal slice, shows the two
aberrant axon pathfinding errors made, 1 and 2, as axons leave the
TCPT to join a longitudinal tract. (F0) Schematic of (F9) illustrating the
aberrant pathfinding of axons leaving the TCPTc. (G) Hypoxic embryo at
96 hpf and higher resolution shown in (G9). (G0) is high-resolution
ventral-to-dorsal single confocal slices. Arrows point to sparse axons
giving rise to the TCPTc. Asterisks demonstrate axons aberrantly turning
caudally and failing to join the TCPTc in the dorsal-most image. (G90)
Schematic of (G0) illustrating the aberrant pathfinding of axons leaving
the TCPTc at different ventral-dorsal levels.
doi:10.1371/journal.pgen.1002638.g002
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mut in the TCPT neurons (n.30 embryos for each
genotype). In contrast, when we expressed hif1a
mut but not hif1a
using Tg(elavl3:Gal4), we observed TCPTc errors (Figure 4G, 4H).
For both hif1a and hif1a
mut we screened and isolated two different
independent UAS transgenic alleles each, and examined fluores-
cence expression when crossed to a Gal4-driver line; all subsequent
experiments were then based on use of a single allele with robust
expression. Quantification of C/L ratios in Tg(elavl3:Gal4);
Tg(foxP2-enhancerA.2:egfpcaax); Tg(UAS: hif1a
mut-2A-TagRFP) embry-
os (n=25 embryos) compared to Tg(elavl3:Gal4); Tg(foxP2-enhancer-
A.2:egfpcaax); Tg(UAS:hif1a-2A-TagRFP) embryos (n=10) was statis-
tically significant (Figure 4K). We confirmed that the hypoxia
pathway is activated by expression of hif1a
mut by showing that igfbp-
1 is up-regulated (Figure 4I, 4J).
To try to further localize the site of action of hypoxia pathway
activation, we expressed hif1a
mut in neurons neighboring the
Figure 3. Developmental hypoxia does not affect general CNS development. Ventral views, rostral to the top, scale bar 50 mm (except E9,
25 mm). Whole-mount embryos, shown as brightfield (A), or confocal maximum intensity z-projections (B–E). (A, A9) in situ hybridization for dlx2
shows no difference in pattern. (B, B9) a-tyrosine hydroxylase (TH) antibody staining pattern is unaffected. (C, C9) Acridine orange shows similar
numbers of apoptotic cells. (D, D9) Phospho-histone H3 antibody staining shows similar numbers of mitotic cells. (E) Confocal image of acridine
orange stain demonstrating region for determining apoptotic cell counts. Inset shows high-magnification (E9) for counting cells in the
100 mm6100 mm area.
doi:10.1371/journal.pgen.1002638.g003
Table 2. Summary of results for experiments involving C/L ratios.
Genotype Variable 1 Variable 2 Variable 3
C/L
Average
C/L St.
Dev.
C/L
SEM
C/L
95% CI p
foxA.2:egfpcaax normoxia 0.639 0.122 0.0354 0.15585 reference
foxA.2:egfpcaax hypoxia 12–24 hpf 0.412 0.24 0.091 0.443 0.0095
foxA.2:egfpcaax hypoxia 24–36 hpf 0.225 0.193 0.0421 0.0826 0.0001
foxA.2:egfpcaax hypoxia 36–48 hpf 0.612 0.233 0.0487 0.0789 0.6522
foxA.2:egfpcaax hypoxia 48–60 hpf 0.719 0.546 0.273 0.536 0.5524
foxA.2:egfpcaax hypoxia 60–72 hpf 0.956 0.9 0.519 1.1081 0.0975
foxA.2:egfpcaax normoxia 0.674 0.237 0.0632 0.0928 reference
foxA.2:egfpcaax normoxia 100 mMDMOG 0.503 0.584 0.162 0.458 0.3915
foxA.2:egfpcaax normoxia 250 mMDMOG 0.428 0.175 0.0619 0.15 0.0163
foxA.2:egfpcaax normoxia 500 mMDMOG 0.284 0.214 0.0713 0.329 0.0015
foxA.2:egfpcaax hypoxia 0.594 0.156 0.034 0.0665 reference
foxA.2:egfpcaax hypoxia 20 mcM CAY10585 0.712 0.19 0.044 0.0854 0.03
elavl3:Gal4; FoxA.2caax; UAS:hif1[mut] normoxia 0.403 0.137 0.028 0.055 reference
elavl3:Gal4; FoxA.2caax; UAS:hif1[mut] normoxia efn morpholino 0.633 0.134 0.0506 0.0992 0.0005
elavl3:Gal4; FoxA.2caax; UAS:hif1 normoxia 0.729 0.291 0.092 0.18 0.0001
elavl3:Gal4; FoxA.2caax; UAS:hif1[mut] normoxia 250 mM Mg 0.346 0.141 0.04252 0.05527 0.2619
foxA.2:egfpcaax hypoxia uninjected 0.274 0.0867 0.0119 0.0233 reference
foxA.2:egfpcaax hypoxia efn morpholino 0.481 0.18 0.0229 0.0449 0.0001
foxA.2:egfpcaax normoxia uninjected 0.339 0.07 0.023 0.0458 reference
foxA.2:egfpcaax normoxia efn morpholino 0.286 0.066 0.018 0.0344 0.0823
foxA.2:Gal4; foxA.2:egfpcaax hypoxia injected UAS:efn 0.548 0.313 0.0809 0.158 0.351
foxA.2:Gal4; foxA.2:egfpcaax hypoxia injected UAS:efnDc 0.745 0.207 0.0822 0.161 0.0006
foxA.2:Gal4; foxA.2:egfpcaax hypoxia uninjected 0.473 0.265 0.0531 0.104 reference
foxA.2:Gal4; foxA.2:egfpcaax normoxia injected UAS:efn 0.572 0.265 0.0944 0.185 0.3459
foxA.2:Gal4; foxA.2:egfpcaax normoxia injected UAS:efnDc 0.649 0.266 0.0897 0.18 0.7809
foxA.2:Gal4; foxA.2:egfpcaax normoxia uninjected 0.682 0.302 0.0675 0.283 reference
foxA.2:egfpcaax hypoxia 0.172 0.07244 0.01811 0.0284 reference
foxA.2:egfpcaax hypoxia 25 mM Mg 0.321 0.14292 0.04519 0.05602 0.0017
foxA.2:egfpcaax hypoxia 100 mM Mg 0.398 0.14426 0.04562 0.0617 0.0001
foxA.2:egfpcaax hypoxia 250 mM Mg 0.451 0.16983 0.05661 0.09424 0.0001
foxA.2:egfpcaax normoxia 500 mcM DMOG 0.624 0.225 0.047 0.0918 reference
foxA.2:egfpcaax normoxia 500 mcM DMOG 100 mM Mg 0.907 0.508 0.106 0.203 0.0187
C/L axonal tract fluorescence intensity ratio analysis comparing commissural axons to longitudinal axons of embryos for the different experiments reported in this
paper. Genotype is listed in the left-hand column; conditions for the experiment are listed in middle columns, and results (C/L ratios including average, standard
deviation, standard error of the mean, and 95% confidence interval) are shown in the right-hand columns, as well as the two-tailed t test p value in the far right column.
doi:10.1371/journal.pgen.1002638.t002
Hypoxia Disrupts Pathfinding through EphrinB2
PLoS Genetics | www.plosgenetics.org 6 April 2012 | Volume 8 | Issue 4 | e1002638Hypoxia Disrupts Pathfinding through EphrinB2
PLoS Genetics | www.plosgenetics.org 7 April 2012 | Volume 8 | Issue 4 | e1002638TCPT axons. We crossed Tg(otpb.A:Gal4-VP16) [30] to Tg(foxP2-
enhancerA.2:egfpcaax), and injected embryos with a plasmid carrying
UAS:hif1a
mut-2A-TagRFP. In these embryos hif1a
mut is expressed
neighboring the TCPT axons as they extend longitudinally, prior
to decussating. We did not observe any defects in formation of the
TCPTc (0%, n=50 embryos, Figure S1). While we can not
exclude the possibility that levels of hif1a
mut were insufficient in
these experiments to disrupt pathfinding, we think it is more likely
that (if a suitable Gal4 line were available) expression targeted to
the CNS midline and/or at the site of the decussation would be
effective. This is based on the expression pattern of a potential
receptor guiding TCPTc axons (below, Figure 6). Thus, the
pathfinding errors in TCPT axons resulting from hypoxia can be
mimicked by activation of the hif1 pathway pan-neuronally, but
not in TCPT neurons alone.
Hypoxia causes pathfinding errors by upregulation of
ephrinB2a
Our finding that hif1 pathway activation has a non-cell-
autonomous effect on TCPT axon pathfinding suggested that
hypoxia affected pathfinding through effects on cell-cell signaling.
The Eph-ephrin signaling system has conserved roles in axon
pathfinding in both vertebrates and invertebrates and controls
aspects of commissural axon pathfinding [31,32]. Further, in C.
elegans hypoxia upregulates the ephrin receptor vab-1, while
knockdown of its ligand efn-2 prevents hypoxia pathfinding defects
[13]. ephrinB2a is the zebrafish gene with greatest sequence
conservation to efn-2 and further is expressed in telencephalic
neurons in the zebrafish embryonic CNS [33].
TCPT neurons and axons express ephrinB2a during 24–36 hpf
(Figure 5A), including in the TCPTc (Figure 5B). Hypoxia caused
increased expression of ephrinB2a (Figure 5C–5E; Figure 6).
Knock-down of ephrinB2a using a translation-blocking morpholino
[33] led to loss of ephrinB2a expression (Figure 6A–6D), and
protected against hypoxia pathfinding errors in the TCPT axons
(Figure 5F, 5G). Further, injection of ephrinB2a morpholino into
Tg(elavl3:Gal4); Tg(foxP2-enhancerA.2:egfpcaax); Tg(UAS:hif1a
mut-2A-
TagRFP) embryos led to rescue of TCPTc errors caused by
misexpression of constitutively active hif1a
mut (Figure 4K). These
results suggest that ephrinB2a mediates some of the disruptive
effects of hypoxia on pathfinding.
To determine how signaling by ephrinB2a is necessary for the
pathfinding by TCPT axons, we expressed a form of ephrinB2a
lacking the cytoplasmic signaling domain, UAS:ephrinB2a(Dcyto-
plasmic) [34] in TCPT neurons using Tg(foxP2-enhancerA.2:Gal4).
Transient injections of UAS:ephrinB2a(Dcytoplasmic), but not full-
length UAS:ephrinB2a, prevented hypoxia-induced pathfinding
errors (Figure 5H; Table 2). There was no effect on the TCPTc
under normoxic conditions by expressing either truncated or full-
length ephrinB2a (Table 2). This demonstrates that ephrinB2a
lacking its cytoplasmic domain is able to decrease guidance errors
cell-autonomously, perhaps by acting as a dominant negative to
interfere with signaling coming from its ‘‘ligand’’ receptor-tyrosine
kinase EphA4a or EphB4. This is consistent with ephrinB2a using a
‘‘reverse’’ signaling mechanism for TCPTc pathfinding [35].
We examined the pathfinding of TCPTc axons relative to the
expression of ephA4a (Figure 6E–F0), a known receptor for
ephrinB2a, that can act during midline commissure formation.
We found that the TCPTc axons travel along the edge of the
midline expressing ephA4a during the period of initial axon
extension at 24 hpf (Figure 6E–6E0). As the TCPTc forms, the
axons cross the midline, again avoiding the ephA4a expression
domain (Figure 6F–6F0). These results suggest that the ephrinB2a-
expressing TCPTc axons are responding to a signal from the
ephA4a-expressing midline cells. Hypoxic up-regulation of
ephrinB2a may disrupt the normal balance of signaling between
the ligand/receptor pair of ephrinB2a/ephA4a, and thereby disrupt
TCPTc formation.
Magnesium protects against hypoxia pathfinding errors
by downregulation of ephrinB2a
Few neuroprotective agents have been demonstrated to affect
neurodevelopmental outcomes of premature infants. Administra-
tion of magnesium sulfate to mothers of infants at risk for
premature delivery improves neurodevelopmental outcomes and
reduces rates of cerebral palsy [14], although the mechanism is
unknown. We sought to determine whether magnesium could
reduce pathfinding errors in hypoxic conditions. Embryos
tolerated magnesium sulfate concentrations ranging from 25 to
250 mM during 24 to 36 hpf with no apparent morphologic
defects, although above 250 mM there was approximately 30%
mortality. Increasing concentrations of magnesium led to rescue of
hypoxia TCPTc pathfinding errors (Figure 7A). We determined
that magnesium can reduce activation of the hif1 pathway, assayed
by in situ for igfbp-1 (Figure 7B, 7C). However, magnesium was
unable to rescue commissure errors in embryos expressing
activated hif1a
mut. Namely, in Tg(elavl3:Gal4); Tg(foxP2-enhancer-
A.2:egfpcaax); Tg(UAS:hif1a
mut-2A-TagRFP) embryos, magnesium
did not rescue pathfinding (Figure 4K). Magnesium did normalize
Efn levels following hypoxia (Figure 6). Interestingly, magnesium
was able to rescue pathfinding errors in the presence of DMOG
(Figure 7D). These results show that magnesium does rescue the
effects of hypoxia on pathfinding. Further, given the results with
DMOG and hif1a
mut, it suggests that magnesium’s primary mode
of action might be through the prolyl hydroxylase or factor
inhibiting hypoxia-inducible factor (FIH) pathways.
Discussion
The increasing numbers of preterm births and associated
adverse neurodevelopmental outcomes has highlighted the limited
understanding of basic mechanisms underlying this problem [6–8].
Indirect radiological evidence in infants born prematurely shows
altered CNS connectivity [9,10], and neurodevelopmental disor-
ders such as autism are associated with changes in axonal and
synaptic gene expression [36].
Figure 4. Developmental hypoxia induces the hif1 pathway and disrupts pathfinding via a non-cell autonomous mechanism. Whole-
mount embryos, 36 hpf, ventral views, rostral to the top, scale bar 50 mm. Images are brightfield views. (A, B) Staining for the igfbp-1 gene activated
by hypoxia shows that hypoxia effectively induces the hif1 pathway. (C) DMOG activates the hif1 pathway, as shown by increased igfbp-1 expression
at 36 hpf following DMOG exposure from 24–36 hpf. (D) Increasing DMOG concentration from 24–36 hpf leads to increased rates of TCPTc
pathfinding errors, assayed by C/L ratios. *p,0.05; ** p,0.005. Error bars SEM. (E–H) Confocal images, 72 hpf, ventral views, rostral top. (E, F) Normal
TCPT pathfinding when hif1a or activated hif1a
mut is expressed in foxP2 neurons. (G, H) Expression of hif1a
mut, but not hif1a, disrupts TCPT
pathfinding when expressed in neighboring neurons. (I, J) Expression of hif1a
mut, but not hif1a, leads to activation of the hypoxia pathway as assayed
by igfbp-1 expression. (K) C/L intensity ratios of experiments. *p,0.05; ** p,0.005. Error bars SEM.
doi:10.1371/journal.pgen.1002638.g004
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PLoS Genetics | www.plosgenetics.org 9 April 2012 | Volume 8 | Issue 4 | e1002638We investigated whether hypoxia, a known complication of
prematurity, can disrupt axon pathfinding. We found that hypoxia
disrupts connectivity in the vertebrate CNS, leading to precise and
reproducible errors in axon pathfinding. The disruption of
pathfinding we observed is not due to apoptosis or broad effects
on CNS development and specification. We have found that the
pathfinding errors are due to hypoxia activation of the hif1
pathway, and can be mimicked by chemical activators of hif1a,o r
by misexpression of a constitutively active form of hif1a. Further,
the pathfinding errors are mediated by ephrinB2a reverse signaling,
and can be rescued by knock-down of ephrinB2a. Finally, we have
found that magnesium sulfate, which is used as a neuroprotective
agent for impending preterm births, can reduce activation of the
hif1 pathway and decrease pathfinding errors following hypoxia.
While hif1a is broadly upregulated following hypoxia, we
determined that activation of the hif1 pathway disrupts pathfinding
through a non-cell-autonomous effect. This may be due to hypoxia
interfering with the balance of ligand-receptor signaling necessary
for normal pathfinding. Thus, the same effect, disrupting axon
guidance, can be achieved by at least one of two mechanisms: by
increasing Eph receptor expression through hif1 pathway activa-
tion in neighboring cells; or by increasing EphrinB2a expression in
TCPT neurons. Usually, EphrinB2a acts as a ligand for one of the
receptor tyrosine kinases (RTK) of the EphA3, EphA4, or EphB4
families, which in turn sets off an intracellular signaling cascade in
the RTK-expressing cell [37]. However, EphrinB2 is also able to
‘‘reverse’’ signal, usually by tyrosine phosphorylation of its own
cytoplasmic domain [35].
We found an evolutionary conservation of the molecular
mechanisms mediating hypoxia’s effects on pathfinding. Pocock
and Hobert [13] described pathfinding defects in the invertebrate
C. elegans caused by hif1 pathway activation and increased
expression of the Eph receptor VAB-1. Prior to our study there
has only been indirect evidence showing disruption of axon
pathfinding from hypoxia in vertebrates, and whether the same
genetic pathways as in C. elegans would be involved was unknown.
There is a marked increased in complexity of CNS structures, and
increase in number of the members in gene families, from
invertebrates to vertebrates. Thus, it is notable both that hypoxia
can specifically disrupt vertebrate axon pathfinding, and that
ephrinB2a, the closest zebrafish homolog to VAB-1, appears to be a
primary mediator of hif1 pathway activation.
In C. elegans, hypoxia leads to increased expression of the Eph
receptor VAB-1 and aberrant crossing of the midline by PVQ
interneurons and HSN motorneurons, a phenotype which can be
rescued by knock-down of the ligand efn-2 [13]. In contrast, we
observed a failure of commissural axon crossing, even though we
observed an up-regulation of the corresponding zebrafish ligand
ephrinB2a. The reason for this difference between the two species,
of increased crossing versus failure to cross the midline, is not
clear, although there are several possible answers. First, it may
reflect a bias in neurons assayed. Most of our analysis was done
with an enhancer for axons that normally cross the midline. It is
possible that with a different enhancer, for example of longitudinal
axons, we might observe aberrant crossing. Second, some of the C.
elegans neurons affected by hypoxia are not strictly ipsilateral in
their normal projections. The PVQ-L crosses the ‘‘midline’’ to
travel with the PVQ-R axon before switching back to the left side,
while the HSN motorneurons project through the nerve ring to the
opposite side of the nervous system [38]. Thus, the crossing of the
midline may reflect a disorganization of pathfinding, rather than a
loss of signals preventing midline crossing. Third, there are
significant differences in midline guidance in the nervous systems
of zebrafish and C. elegans. The C. elegans midline is defined by a
guidepost function of midline motor neurons [39], whereas in
zebrafish and other vertebrates glial bridges provide some of this
role [40]. VAB-1 over-expression in C. elegans is able to produce
axon guidance defects [41], so perhaps differences in the midline
structures of the nervous systems results in different expression
patterns and usage of the eph/ephrin signaling pairs.
We found that hypoxia caused increased expression of
ephrinB2a by hypoxia, and subsequent failure of TCPTc axons
to cross the midline. In mammals, ephB and ephA receptor family
members, and ephrinB ligands, guide development of the corpus
callosum, by a complex series of actions including effects on
midline glial growth, on modulating axon responsiveness, and on
reverse signaling in axons as they cross the midline [42,43]. In
zebrafish, the ligand ephrinB2a is expressed in telencephalic
neurons and their axons as they extend towards the midline [33,
this study], and we have found that the receptor ephA4a is
expressed in the midline of the CNS during axon extension. These
results support a model where signaling between ephrinB2-
expressing axons and ephA4a-expressing midline cells helps guide
the axons as they cross the midline. Alterations in levels of ligand
or receptor, for example by hypoxia-induced up-regulation of
ephrinB2, could thus impair normal TCPTc formation.
Comparing degree of hypoxia in different animal species is
difficult, and extrapolating 1% hypoxia (1% pO2) in zebrafish to
equivalent effects in premature infants is not straightforward. Since
zebrafish can survive extended periods of hypoxia and even anoxia
[this study; 15,16], 1% hypoxia might be equivalent to relatively
‘‘mild’’ hypoxia in human infants. Premature infants at 36 weeks
gestation have been found to spend more than 8 hours/day at less
than 90% oxygen saturation [12], and infants with chronic lung
disease or congenital heart disease have more significant decreases
in oxygenation. Finally, using 1% hypoxia to examine the
mechanisms underlying hypoxia’s effect allowed us to examine
the genetic pathways and more noticeable effects on CNS
pathfinding. It seems likely that less stringent hypoxia would have
similar, but less marked effects. Similarly, since typical human
serum magnesium levels are ,1 mM, the human physiological
corollary to bathing zebrafish in 250 mM magnesium sulfate is
unclear. However, the current magnesium dose given to expectant
mothers is a single bolus dose of 4 g, followed by a continuous
infusion of 2 g/hour until delivery [14]. Further, it is not known
what fetal magnesium levels are following the dose, and whether
there are differences in neurodevelopmental outcomes depending
on overall dose or post-natal levels. While there are obvious
limitations to extrapolating our findings to human infants, it is
possible that increasing magnesium levels in human infants could
Figure 5. ephrinB2a mediates the hypoxia-induced TCPT pathfinding errors. (A–B) ephrinB2a is expressed in TCPT neurons. Confocal
maximum intensity projections of whole-mount embryos, double immunohistochemistry for GFP and EfnB2a, ventral views, rostral top, scale bar
50 mm. (A–A0) TCPT neurons express ephrinB2a as they begin to extend axons. (B–B0) TCPT commissural axons express ephrinB2a as they cross the
midline. (C–D) Hypoxia leads to increased expression of EfnB2a. Maximum intensity projections of 36 hpf embryos, ventral views, rostral to the top,
EfnB2a immunohistochemistry. (E) Quantification of EfnB2a levels, normalized to normoxia. *p,0.05. Error bars SEM. (F) Knockdown of EfnB2a
expression with morpholino rescues TCPTc pathfinding. Tg(foxP2-A.2:caax) embryo at 72 hpf; confocal maximum intensity projection, ventral view,
rostral top, scale bar 50 mm. (G) C/L intensity ratio quantifications show ephrin morpholino rescue of hypoxia pathfinding errors. *p,0.01; ** p,0.001.
Error bars SEM. (H) C/L intensity ratios show UAS:ephrinDc rescues hypoxia pathfinding errors. ** p,0.001. Error bars SEM.
doi:10.1371/journal.pgen.1002638.g005
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PLoS Genetics | www.plosgenetics.org 10 April 2012 | Volume 8 | Issue 4 | e1002638Figure 6. Hypoxia increased ephrinB2a expression in a pattern complementary to its receptor ephA4a. (A) Anti-EfnB2a intensity values
at 36 hpf in the telencephalon, either following normoxia, or either hypoxia (1%), or hypoxia with 100 mM magnesium sulfate, from 24–36 hpf. (B)
Confocal image of embryo at 36 hpf stained for ephrinB2, demonstrating the region of interest used to calculate a-ephrinB2 intensity. (C, D) Confocal
images of embryos at 48 hpf stained for a-ephrinB2, demonstrating that efn morpholino (mo) effectively reduces ephrinB2a expression (D). (E–F0)
Whole-mount double immunohistochemistry and in situs for GFP and ephA4a, respectively, in Tg(foxP2-A.2:caax) embryos. (E–E0) During initial axon
extension at 24 hpf, axons (arrowhead) travel along the edge of ephA4a expression domain. (F–F0) At 30 hpf, as TCPTc forms (arrow), the axons avoid
the area of ephA4a expression.
doi:10.1371/journal.pgen.1002638.g006
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mechanisms and genetic pathways activated by hypoxia in
zebrafish may also be relevant in human development.
In addition to conservation of molecular mechanisms, is there
conservation of effects of hypoxia on specific subsets of axon
pathfinding in humans? Our work found that only a subset of
axons was affected by hypoxia. For example, using our transgenic
reporter line, we found that commissural axons extending from
forebrain neurons were disrupted, whereas we did not observe
problems in the longitudinal axons or in the optic chiasm. In
humans, prematurity has been shown to affect connectivity of
commissural structures, including the corpus callosum [10], as well
as non-commissural axon tracts such as the internal capsule,
superior fasciculus, uncinate fasciculus, and external capsule
[10,45]. These changes in connectivity are correlated with
decreased overall intelligence quotient (IQ) score [46], with
particular correlations noted between corpus callosum disruption
and IQ as well as attention-deficit hyperactivity disorder [47,48].
In addition, autism is associated with prematurity and disruptions
of both intra-hemispheric and inter-hemispheric connectivity
[49,50]. A significant caveat to these studies, however, is the
indirect nature of the measurements, relying upon fractional
anisotropy based on water diffusion measured by magnetic
resonance imaging, and that differences in cortical volume and/
or synaptic changes could also impact the clinical findings.
This study raises several issues for future study. First, we found
considerable variability in the degree of disruption of axon
pathfinding from animal to animal. Following hypoxia, some
animals had no TCPT commissural axons cross the midline, while
in other animals the TCPTc was hardly or not affected. This
suggests that other homeostatic mechanisms, as yet unknown, may
help prevent or ameliorate the pathfinding errors. A second
question concerns why certain axons (and neurons) are particularly
susceptible to hypoxia. While we were found that the TCPTc was
affected following hypoxia, in other axon groups, for example the
optic tracts, we never observed pathfinding errors following
hypoxia. Is this due to some intrinsic feature of different neuron
types, or because certain molecules, such as ephrinB2a, are
expressed only in certain neurons? Since we did observe errors
in other axon tracts when we used pan-axonal immunohisto-
chemistry, it is likely that a wider subset of neurons and axon tracts
are affected. Third, does hypoxia affect the development of the
other main determinant of connectivity, namely synapses?
Microarray data in rodents has shown that hypoxia causes altered
expression of multiple synaptic genes [51]. Additional studies will
need to characterize effects of hypoxia on synapse development.
Fourth, magnesium was protective against the hypoxic pathfinding
disruption. Magnesium sulfate is currently used as a single-dose
agent immediately prior to preterm births [14], but future work
could examine whether elevated magnesium levels are associated
with improved neurodevelopmental outcomes, as well as what the
molecular target of magnesium is.
Our finding of disrupted connectivity in the brain following
hypoxia and the involvement of a conserved genetic pathway
suggests one mechanism that may contribute to the diverse
neurodevelopmental impairments seen in premature infants.
Premature infants have elevated rates of attention-deficit disorder,
autism, cerebral palsy, epilepsy, psychiatric disorders, and
cognitive impairment [2–5], and perhaps disruptions of connec-
tivity might be responsible for some of these outcomes. Although
cognitive impairment is the most common of these chronic
neurodevelopmental problems [4], it is not known, for example,
why certain infants develop autism as opposed to attention-deficit
disorder, or what characteristics of the hypoxia lead to different
clinical outcomes. The identification of the precise effects and
molecular mediators of hypoxic injury in the developing vertebrate
brain offers the possibility for improved understanding and novel
therapeutic approaches.
Materials and Methods
Ethics statement
All zebrafish experiments were performed with supervision and
in strict accordance of guidelines from the University of Utah
Institutional Animal Care and Use Committee (IACUC),
regulated under federal law (the Animal Welfare Act and Public
Health Services Regulation Act) by the U.S. Department of
Agriculture (USDA) and the Office of Laboratory Animal Welfare
at the NIH, and accredited by the Association for Assessment and
Accreditation of Laboratory Care International (AAALAC).
Fish stocks and embryo raising
Adult fish were bred according to standard methods. Embryos
were raised at 28.5uC in E3 embryo medium and staged by time
and morphology [52]. For in situ staining and immunohistochem-
istry, embryos were fixed in 4% paraformaldehyde (PFA) in PBS
overnight (O/N) at 4uC, washed briefly in PBS with 0.1% Tween-
20, dehydrated, and stored in 100% MeOH at 220uC until use.
Transgenic fish lines and alleles used in this paper were the
following: Tg(foxP2-enhancerA.2:egfp-caax)
zc69; Tg(foxP2-enhancerA.2:-
Figure 7. Magnesium sulfate administration protects against hypoxia-related axon pathfinding defects. (A) C/L intensity ratios of
increasing magnesium concentrations (mM). *p,0.01; ** p,0.001. Error bars SEM. (B, C) Magnesium reduces activation of the hif1a pathway, as
shown by decreased igfbp-1 expression following hypoxia and concurrent magnesium exposure from 24–36 hpf. Bright-field images; ventral views,
rostral top, scale bar 50 mm. (D) C/L intensity ratios shows rescue by magnesium of DMOG exposure from 24–36 hpf. *p,0.05. Error bars SEM.
doi:10.1371/journal.pgen.1002638.g007
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zc72; Tg(elavl3:Gal4-VP16413–470); Tg(UAS:hif1a -
2A-egfpcaax)
zc73; Tg(UAS:hif1a -2A-TagRFP)
zc74; Tg(UAS: hif1a
mut-
2A-egfpcaax)
zc75; Tg(UAS: hif1a
mut-2A-TagRFP)
zc76, where 2A is a
viral hydrolase peptide sequence [29]; and Tg(otpb.A:Gal4-
VP16413–470, myl7:EGFP)
zc57 [30]. Injection of DNA constructs
and generation of stable transgenic lines was performed essentially
as described [17]. Lines are available upon request.
Hypoxia reagents
To induce hypoxia, embryonic zebrafish were placed in a sealed
plexiglass chamber connected via a controller that monitored and
adjusted nitrogen gas flow to a desired pO2 set point (Biospherix Ltd.).
We observed that equilibration of oxygen partial pressures in water
could take several hours measured with a dissolved oxygen water meter
(Control Company). Therefore we pre-equilibrated all solutions to
either normoxia or hypoxia for at least 4 hours before use, and
transferred embryos into and out of pre-equilibrated solutions. At the
desired time, embryos were placed into media that had been
equilibrated to the hypoxic conditions. To terminate hypoxia, embryos
were returned to media kept in normoxic conditions. Morphological
staging was used to help determine age at fixation for analyses.
Scoring TCPT axon errors, C/L intensity ratios
To assay whether a TCPT pathway had decreased commissural
crossing, we measured the total fluorescence intensity (average
intensity x area) of a rectangular area placedover the commissureor
longitudinal tract. A confocal z-stack was taken of the region using
identical confocal settings (206 objective, laser power 10%, gain
1.25%, offset 2%, PMT 400, speed 2.5 ms/pixel). We used ImageJ
to calculate an average intensity projection of 10 slices (step size
2.8 mm), then measured total fluorescence intensity in a rectangle of
set size (0.1260.25; 10 mm630 mm) over the midline of the
commissural TCPT pathway or over the longitudinal axons prior
to their decussation into the TCPT. A ratio of the commissural vs.
longitudinal axon intensity was calculated (C/L ratio) (Figure 1F).
Some experimental variation was noted, and so results were only
directly compared for experiments performed on the same day. For
determination of C/L ratios of hypoxia effects at different ages
(Figure 1G), 24 or more embryos were imaged per age.
Immunohistochemistry and in situ hybridization
Immunohistochemistry was performed as previously described
[17,30]. Antibodies used were: mouse anti-acetylated tubulin
1:250, rabbit polyclonal anti-tyrosine hydroxylase 1:400 (Milli-
pore), mouse monoclonal anti-GFP 1:250 (Millipore), goat
polyclonal anti-EphrinB2a 1:20 (R&D Biosystems), rabbit anti-
phosphohistone H3 1:500 (pH 3 polyclonal, Upstate Biotechnol-
ogy), Cy-3 anti-rabbit 1:400, Alexa 488 donkey anti-mouse 1:400
(Invitrogen), Alexa 555 rabbit anti-goat 1:100 (Invitrogen).
Double immunohistochemistry for GFP and EfnB2a was
performed by permeabilization using 10 mg/ml Proteinase K in
PBST, re-fixation for 109 with 4% PFA, further permeabilization
with 0.1M citrate and 0.1% Triton in PBS, incubation with mouse
anti-GFP and goat anti-ephrinB2a, followed by washing with
PBST/1% DMSO and incubation with donkey anti-mouse Alexa
488 and rabbit anti-goat Alexa 555.
Whole-mount in situ labeling for igfbp-1 was performed using an
anti-sense probe generated by NotI digestion and transcription
using T3 polymerase from pCR4 Blunt-ZF IGFBP-1 [22], as
previously described [53].
Cloning and transgenic fish lines
Expression clones were built using the Tol2 kit [54] and
recombination reactions with Gateway (Invitrogen) plasmids. For
clones lacking an expressed fluorescent marker, either a
cmlc2:EGFP (official nomenclature myl7:EGFP) or cmlc2:TagRFP
transgenesis marker was used in the final construct. The identity of
constructs was confirmed by restriction enzyme digests and by
sequencing on both strands (for coding sequences) or by partial
end-sequencing (for enhancers). Specific plasmids used for cloning
were p5E-foxP2-enhancerA.2; p5E-elavl3; p5E-10xUAS; pME-
basEGFP-caax (middle entry clone with EGFP-caax preceded by
minimal promoter); pME- basGal4-VP16413–470; pME- hif1a (no
stop) or pME- hif1a
mut (no stop); p3E-pA; p3E-2A-eGFPcaax-pA;
p3E-2A-TagRFP-pA; into either pDestTol2pA2, or pDest-
Tol2CG2/pDestTol2CR3 (pDestTol2pA3 with cmlc2:EGFP or
cmlc2:TagRFP transgenesis marker, respectively) [17,29,30,54].
We cloned and sequenced the zebrafish hif1a cDNA (hif1ab).
We generated a constitutively active form of hif1a, hif1a
mut,b y
mutating proline 621 to alanine in the conserved LXXLAP motif
on HIF-1 [28]. This mutation prevents the hydroxylation of HIF-1
and thereby its subsequent proteosomal degradation. Zebrafish
hif1a was cloned based on the GenBank sequence AY326951,
adding attB1F and attB2R sequences for cloning using the
Gateway system (Invitrogen): forward primer: bp 230–250 (hif1a
sequence italicized, attB1F regular type, start codon underlined)
59-GGGGACAAGTTTGTACAAAAAAGCAGGCTACCCAGG-
AATGGATACTGGAG-39; reverse primer bp 2587–2606 59-
GGGGACCACTTTGTACAAGAAAGCTGGGTGGAAGAGT-
GTCCGCAGTTGC-39. PCR was performed using Tuebingen wild-
type cDNA, and the resulting 2.4 kb fragment was recombined
into pDONR221 and sequenced. To generate the hif1a
mutcon-
struct, the proline at position 557 was changed to alanine with site-
directed mutagenesis by overlap PCR (CCT to GCT at nucleotide
1677) and the final clone was confirmed by full-length sequencing.
C-terminal fusion constructs of hif1a were made by overlap PCR
changing the stop codon (TGA) to glycine (GGA).
Microscopy and image analysis
Image acquisition and analysis were performed as described
previously [17]. Immunostained embryos were transferred step-
wise into 80% glycerol/20% PBST, mounted on a glass slide with
a #0 coverslip placed over a well made using electrical tape, and
imaged on a confocal microscope. Confocal stacks were projected
in ImageJ, and images composed with Adobe Photoshop and
Illustrator. For imaging fluorescent immunohistochemistry and
bright-field in situ staining for Figure 6 E0 and F0, the ‘‘Exclusion’’
function on Adobe Photoshop was used to combine the layers,
with the ‘‘Exposure’’ set at 24.0 for the bright-field image.
Determination of a-Efn staining intensity was calculated using
identical confocal settings for imaging all of the embryos (laser
power 10%, gain 1.25%, offset 2%, PMT 400, speed 2.5 ms/pixel).
Intensities were calculated in a rectangle of set size (0.1260.25;
10 mm630 mm) over the midline of the telencephalon using
maximum intensity projections of 5 z-slices (step size 2.8 mm)
(Figure 6B).
Morpholino injections
One-cell stage embryos were injected with 1 nl of 3 ng/nl
EfnB2a translation-blocking morpholino [33] as previously
described [17].
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Live control and hypoxic embryos (72 hpf) were collected into
1.5 mL tubes, stained for 309 in 5 mg/mL acridine orange in E3
embryo medium, then washed for 309 at RT in E3 on a nutator.
Embryos were then anesthetized and mounted in low-melt agarose
containing tricaine. Live imaging was performed using a confocal
microscope (PMT 581V, scan size 6406480, speed 1.79 s/scan,
UPLFL 206objective, z-step size 2.8 mm, laser intensity 15.0%)
Scoring apoptosis/acridine orange staining
ImageJ was used to score 20 z-slices (step size 2.8 mm) counting
dorsally form the equator of the lens. A square with an area of
100 mm
2 was drawn with its top boundary immediately caudal to
the olfactory pits, sides immediately medial to the eyes, and lower
boundary at the center (rostral to caudal axis) of the lens
(Figure 3E, E9). Apoptotic cells were counted that lay within the
square including those that contacted the boundaries.
Drug and Mg
2+ treatment
Embryos were manually dechorionated prior to 24 hpf. For
Mg
2+ treatment, E3/PTU-containing solution was mixed with the
appropriate concentration of magnesium sulfate (25–250 mM); for
dimethyloxalylglycine (DMOG) (Sigma) or CAY10585 (Cayman
Chemical), the drug was diluted in 0.1% DMSO and added to
E3/PTU to make final concentrations of 100–750 mM (DMOG)
or 20 mM (CAY10585). Embryos were incubated during an
exposure period from 24–36 hpf, and at 36 hpf embryos were
returned to E3/PTU. Fixation with 4% PFA occurred at 72 hpf.
Supporting Information
Figure S1 Expression of activated hif1a
mut near TCPT axons
does not disrupt axon pathfinding. Confocal whole-mount images,
double anti-GFP and anti-RFP immunohistochemistry, of 72 hpf
embryo Tg(foxP2-A.2:caax), Tg(otpb.A:Gal4-VP16), injected with
UAS:hif1a
mut-2A-TagRFP, ventral views, rostral top, maximum
intensity projections, scale bars 50 mm. Arrow points to axons
expressing hif1a
mut near the TCPT.
(TIF)
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